Photo: Getty Images
Here's Today's Feel-Good Story:
Oxford's R21 malaria vaccine has finally been approved for use after 8 years of testing and trials.
One of the highest mortality groups for malaria is infants between 5 months and 3 years of age. Two of West Africa's biggest economies, Ghana and Nigeria, are now approved to distribute the vaccine.
“We expect R21 to make a major impact on malaria mortality in children in the coming years, and in the longer term [it] will contribute to overall final goal of malaria eradication and elimination,” Professor Adrian Hill, director of the Jenner Institute at the University of Oxford, where the vaccine was invented, said.
Watch the video below!